CTRI/2012/04/002605Other未知
Randomized, Double Blind, Placebo Controlled Trial of Periappendiceal Injection of Triamcinolone in Idiopathic Ulcerative Colitis
试验速览
- 阶段
- 未知
- 状态
- Other
- 发起方
- PGIMER
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •a.Male or female patients 18 years of age or older with an established diagnosis of IUC
- •b.In clinical remission for at least 3 months on 5-ASA at a stable dose ranging from 1.6 to 2.4 g/day
- •c.Patient had achieved remission with a corticosteroid > 20 mg/day prednisolone or an alternative medication and had successfully ceased steroid therapy
- •d.Patients undergoing colonoscopy for assessment of the extent of the disease
排除标准
- •a.Patients on immunomodulators like azathioprine, 6 mercaptopurine and mycophenolate mofetil
- •b.Patients with severe cardiovascular diseases
- •c.Patients with laboratory abnormalities indicating anemia (hemoglobin < 9 g/dL), leukopenia, thrombocytopenia, or abnormal coagulation;
- •d.Patients with renal or liver disease, chronic pancreatitis, diabetes mellitus, mental disorders or gallstone
- •e.Patients with infection, sepsis, or pneumonia
- •f.Pregnant or nursing women.
- •g.History of appendectomy
研究者
相似试验
尚未招募
不适用
Project goal is eliminate HIV within all systems of the body and to prevent its transmission.HIV/AIDSupper respiratory tract infectionsTuberculosisMalariaPACTR201401000720267Health Gateway (PTY) Ltd200
已完成
4 期
Efficacy and Safety of Acne Lotion in the Treatment of Facial Acne VulgarisCTRI/2011/05/001758Mayer Organics Pvt Ltd50
进行中（未招募）
1 期
APatients suffering from unilateral lateral epicondylitis, persistent for more than 3 months or recurrent and not having responded to at least one reference treatmentMedDRA version: 20.0 Level: PT Classification code 10014971 Term: Epicondylitis System Organ Class: 10022117 - Injury, poisoning and procedural complicationsEUCTR2017-001709-33-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)150
进行中（未招募）
不适用
Ferric Carboxymaltose Versus Placebo in Patients with Congestive Heart FailureEUCTR2012-001134-33-DEniversitätsklinikum Ulm
已完成
不适用
Effectivenessof L-Arginine supplementation for treatment of patients with pulmonary tuberculosisTuberculosis.Tuberculosis of lung, confirmed by sputum microscopy with or without cultureIRCT201211179855N2Arak University of Medical Sciences60